Rifadin (rifampicin) by Sanofi-Aventis U.S. LLC: new human prescription drug listing

Rifadin: new human prescription drug listing. Dated 94 days ago, it serves as a historical benchmark. Score 40/100. As of 2026-11-04, from U.S. FDA National Drug Code (NDC) Directory via openFDA.

Data as of · Compiled by Zalwin from U.S. FDA National Drug Code (NDC) Directory via openFDA

Free preview: all 9 published fields of this record are shown below. Locked: 499 related FdaNdcDirectoryPulse records and the 5-column CSV export.

FieldValue
ProductRifadin
Generic namerifampicin
NDC0068-0660
LabelerSanofi-Aventis U.S. LLC
Product typeHUMAN PRESCRIPTION DRUG
Approval pathwayUNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
Dosage formKIT
Marketing start2026-08-03
Package configurations1
Peer records CSV (500 records) 🔒 Click to unlock →
CRM-ready export with official source URLs 🔒 Click to unlock →

View the official record

Markdown version

Watch Rifadin

Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.

Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.

Free first: a 10-record sample of records

See the real columns before you buy. One confirmation email, nothing else unless you opt in.

Unlock Rifadin + 500 peer records (CSV)

Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Product · Labeler · Pathway · Form · Listed · official source URL

  • Source agency: U.S. FDA National Drug Code (NDC) Directory via openFDA
  • Record date: 2026-08-03
  • Data refreshed: 2026-11-04
  • Refunds on request within 14 days

Search all records free →

Top FdaNdcDirectoryPulse records (HUMAN PRESCRIPTION DRUG first): Cyclophosphamide by Amneal Pharmaceuticals LLC · Cyclophosphamide by Amneal Pharmaceuticals LLC · YESAFILI (aflibercept-jbvf) by Biocon Biologics Inc. · CIPROFLOXACIN OTIC (ciprofloxacin) by Alembic Pharmaceutical · WELTRUZA (olanzapine) by Teva Pharmaceuticals USA, Inc. · Browse all by state and category →

LIVE PUBLIC DATA Source: U.S. FDA National Drug Code (NDC) Directory via openFDA · Last refreshed: Wed, 04 Nov 2026 18:12:05 GMT

Is this your business? Add a "Listed on Zalwin" badge to your site

Paste this snippet into your website. It links to this public record; nothing is tracked on your site.

Listed on Zalwin badge preview

Peer benchmark and outreach value: Rifadin and 1,345 HUMAN PRESCRIPTION DRUG peers

  • HUMAN PRESCRIPTION DRUG FdaNdcDirectoryPulse records like this one: 1,345
  • Timing: Low: older than 30 days
  • Estimated pipeline if you contact every HUMAN PRESCRIPTION DRUG peer: $269,000 (peers × rate × deal size; an estimate from your assumptions, not a forecast)

Search, filter and export more FdaNdcDirectoryPulse records

Run instant live search with these filters Download free sample CSV

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

40 / 100 Launch Signal Score

  • Prescription or biologic product.

What is the FdaNdcDirectoryPulse record for Rifadin?

Rifadin by Sanofi-Aventis U.S. LLC: new human prescription drug listing (UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE) starting 2026-08-03.

How does Rifadin compare to other FdaNdcDirectoryPulse records?

It is 94 days old; check the official source for later updates before acting.

Rifadin vs. top 3 peers

OrganizationLocationRecord date
RifadinHUMAN PRESCRIPTION DRUG2026-08-03
YESAFILIHUMAN PRESCRIPTION DRUG2026-11-03
LEROCHOLHUMAN PRESCRIPTION DRUG2026-11-01
CAMCEVI ETMHUMAN PRESCRIPTION DRUG2026-10-31

Related records

FdaNdcDirectoryPulse: Prescription (Rx) FdaNdcDirectoryPulse: Other

How to monitor Rifadin and peer other records

Get new FdaNdcDirectoryPulse records like Rifadin by email (free, weekly)

We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.

Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.

See this week's digest

Get new listings in your categories

FdaNdcDirectoryPulse emails new drug listings matching your pathway and product type.

See plans

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.

Often used together